Fluticasone PCD Pharma Franchise Company
Cafoli Lifecare offers an extensive Fluticasone PCD pharma franchise built on 25 formulations spanning inhalers, rota caps, nasal sprays, creams and capsules, all manufactured at WHO-GMP certified facilities. This depth gives franchise partners a complete respiratory and dermatology corticosteroid line.
What is Fluticasone?
Fluticasone is a potent synthetic corticosteroid with strong local anti-inflammatory activity and minimal systemic absorption at recommended doses. Depending on formulation it controls airway inflammation in asthma and allergic rhinitis or skin inflammation in dermatoses. Read its profile on MedlinePlus.
Therapeutic Applications
Fluticasone is prescribed as an inhaler or rota cap for maintenance control of asthma and COPD (often combined with a long-acting beta-agonist), as a nasal spray for allergic rhinitis and nasal polyps, and as a cream for inflammatory skin conditions such as eczema and dermatitis. Prescribers include pulmonologists, ENT surgeons, dermatologists, paediatricians and physicians.
Why Fluticasone is a High-Potential Molecule for Distributors
Fluticasone anchors modern inhaled-steroid and combination-inhaler therapy — the backbone of long-term asthma and COPD control — which means chronic, years-long repeat use. Its span across respiratory, ENT and dermatology channels plus a large 25-formulation range (including premium combination inhalers) lets a distributor build an entire respiratory-plus-derma portfolio around one molecule with dependable recurring demand.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Fluticasone
- PubChem: Fluticasone
Our formulations of Fluticasone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: